FindTrial
Sign In

Study of fat markers in blood as a tool to detect or stage breast cancer

Diagnostic potential of serum fatty acid methyl esters in Invasive Ductal Carcinoma of the Breast: a case control observational study - NIL

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/07/090734
Enrollment
80
Registered
2025-07-11
Start date
Unknown
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C509- Malignant neoplasm of breast of unspecified site

Interventions

Intervention1: Nil: Nil

Sponsors

Kasturba Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Female patients within the age group of 18 years to 60 years with Invasive Ductal Carcinoma of the breast or benign breast diseases will be recruited for the study. Voluntarily consenting women who have undergone mammography (during routine screening) and are negative for beingn breast masses will be recruited as healthy controls.

Exclusion criteria

Exclusion criteria: Patients with other cancers, congenital metabolic disorders, chronic kidney disease, liver dysfucntion, acute infectious diseases, and pregnant females and women on treatment for fibroadenoma and fibrocystic disease will be excluded from the study.

Design outcomes

Primary

MeasureTime frame
levels of serum fatty acid methyl esters in patients vs healthy controlsTimepoint: baseline—

Secondary

MeasureTime frame
nilTimepoint: nil—

Countries

India

Contacts

Public ContactDr Vijetha Shenoy Belle

Kasturba Medical College Manipal

vijetha.shenoy@manipal.edu9844667820

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026